» Articles » PMID: 33332468

A Prospective Survey of Streptococcus Pyogenes Infections in French Brittany from 2009 to 2017: Comprehensive Dynamic of New Emergent Emm Genotypes

Overview
Journal PLoS One
Date 2020 Dec 17
PMID 33332468
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Streptococcus pyogenes or group A Streptococcus (GAS) causes diseases ranging from uncomplicated pharyngitis to life-threatening infections. It has complex epidemiology driven by the diversity, the temporal and geographical fluctuations of the circulating strains. Despite the global burden of GAS diseases, there is currently no available vaccination strategy against GAS infections. This study, based on a longitudinal population survey, aimed to understand the dynamic of GAS emm types and to give leads to better recognition of underlying mechanisms for the emergence of successful clones. From 2009 to 2017, we conducted a systematic culture-based diagnosis of GAS infections in a French Brittany population with a prospective recovery of clinical data. The epidemiological analysis was performed using emm typing combined with the structural and functional cluster-typing system for all the recovered strains. Risk factors for the invasiveness, identified by univariate analysis, were computed in a multiple logistic regression analysis, and the only independent risk factor remaining in the model was the age (OR for the entire range [CI95%] = 6.35 [3.63, 11.10]; p<0.0001). Among the 61 different emm types identified, the most prevalent were emm28 (16%), emm89 (15%), emm1 (14%), and emm4 (8%), which accounted for more than 50% of circulating strains. During the study period, five genotypes identified as emm44, 66, 75, 83, 87 emerged successively and belonged to clusters D4, E2, E3, and E6 that were different from those gathering "Prevalent" emm types (clusters A-C3 to 5, E1 and E4). We previously reported significant genetic modifications for emm44, 66, 83 and 75 types resulting possibly from a short adaptive evolution. Herein we additionally observed that the emergence of a new genotype could occur in a susceptible population having specific risk factors or probably lacking a naturally-acquired cluster-specific immune cross-protection. Among emergent emm types, emm75 and emm87 tend to become prevalent with a stable annual incidence and the risk of a clonal expansion have to be considered.

Citing Articles

Lineage ST62/87: The International Spread of This Potentially Invasive Lineage.

Martini C, Silva D, Viana A, Planet P, Figueiredo A, Ferreira-Carvalho B Antibiotics (Basel). 2023; 12(10).

PMID: 37887231 PMC: 10603930. DOI: 10.3390/antibiotics12101530.


pBFK, a new thermosensitive shuttle vector for gene deletion by homologous recombination.

Boukthir S, Gaudu P, Faili A, Kayal S Heliyon. 2023; 9(6):e16720.

PMID: 37346331 PMC: 10279790. DOI: 10.1016/j.heliyon.2023.e16720.


Analysis of the Genomics and Mouse Virulence of an Emergent Clone of Streptococcus dysgalactiae Subspecies .

Beres S, Olsen R, Long S, Eraso J, Boukthir S, Faili A Microbiol Spectr. 2023; :e0455022.

PMID: 36971562 PMC: 10100674. DOI: 10.1128/spectrum.04550-22.


Increasing Incidence of Invasive Group A Streptococcus Disease, Idaho, USA, 2008-2019.

Dunne E, Hutton S, Peterson E, Blackstock A, Hahn C, Turner K Emerg Infect Dis. 2022; 28(9):1785-1795.

PMID: 35997313 PMC: 9423907. DOI: 10.3201/eid2809.212129.


A Chimeric Penicillin Binding Protein 2X Significantly Decreases in Vitro Beta-Lactam Susceptibility and Increases in Vivo Fitness of Streptococcus pyogenes.

Olsen R, Zhu L, Mangham R, Faili A, Kayal S, Beres S Am J Pathol. 2022; 192(10):1397-1406.

PMID: 35843262 PMC: 9552024. DOI: 10.1016/j.ajpath.2022.06.011.


References
1.
Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A . Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2009; 47(4):1155-65. PMC: 2668334. DOI: 10.1128/JCM.02155-08. View

2.
Davies H, McGeer A, Schwartz B, Green K, Cann D, Simor A . Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996; 335(8):547-54. DOI: 10.1056/NEJM199608223350803. View

3.
OLoughlin R, Roberson A, Cieslak P, Lynfield R, Gershman K, Craig A . The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis. 2007; 45(7):853-62. DOI: 10.1086/521264. View

4.
Frost H, Laho D, Sanderson-Smith M, Licciardi P, Donath S, Curtis N . Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity. Clin Infect Dis. 2017; 65(9):1523-1531. PMC: 7263703. DOI: 10.1093/cid/cix599. View

5.
Sitkiewicz I, Green N, Guo N, Mereghetti L, Musser J . Lateral gene transfer of streptococcal ICE element RD2 (region of difference 2) encoding secreted proteins. BMC Microbiol. 2011; 11:65. PMC: 3083328. DOI: 10.1186/1471-2180-11-65. View